Spotlight on the Treatment Armamentarium of Concomitant Psoriasis and Inflammatory Bowel Disease: A Systematic Review.
Conclusions: Psoriasis and IBD can be treated concurrently as they share common inflammatory pathways. TNF-α inhibitors and IL-12/23 have been successful in treating both psoriasis and IBD. IL-17 inhibitors are recognized treatments for psoriasis but have the potential to exacerbate IBD. Newer molecules require further clinical trials and real-life studies in order to confirm their efficacy and safety.
PMID: 33074781 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Acitretin | Allergy & Immunology | Arthritis | Clinical Trials | Databases & Libraries | Dermatology | Enbrel | Humira | Inflammatory Bowel Disease | Methotrexate | Prograf | Psoriasis | Psoriatic Arthritis | Remicade | Restasis | Rheumatology | Science | Skin | Stelara | Study | Tacrolimus | Ulcerative Colitis